Can Abilify Maintena (aripiprazole) be used for bipolar II disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Abilify Maintena Be Used for Bipolar II Disorder?

No, Abilify Maintena is not FDA-approved for bipolar II disorder and should not be used for this indication. The FDA label explicitly states that Abilify Maintena is indicated only for "maintenance monotherapy treatment of bipolar I disorder in adults" 1.

Key Distinction: Bipolar I vs. Bipolar II

The critical difference lies in the diagnostic criteria and treatment evidence base:

  • Bipolar I disorder involves full manic episodes (the indication for Abilify Maintena)
  • Bipolar II disorder involves only hypomanic episodes with major depressive episodes

Why This Matters Clinically

The evidence for aripiprazole (the active ingredient in Abilify Maintena) in bipolar II is limited to oral formulations at very low doses for depressive episodes, not for maintenance treatment:

  • A 2017 study found that low-dose oral aripiprazole (1-5 mg) showed efficacy in bipolar II depression 2
  • A 2015 study demonstrated benefits with oral aripiprazole 5-15 mg as adjunct therapy in bipolar I or II depression 3
  • However, these studies used oral formulations, not the long-acting injectable, and focused on acute depressive episodes, not maintenance

The Evidence Gap

Multiple systematic reviews confirm aripiprazole's efficacy is established for:

  • Acute mania in bipolar I disorder 4, 5, 6
  • Maintenance prevention of manic episodes in bipolar I 4, 6

But aripiprazole consistently fails to show efficacy for:

  • Acute bipolar depression (weak effect size of 0.17) 6
  • Prevention of depressive relapses 4, 5

Clinical Algorithm for Bipolar II Maintenance

For bipolar II disorder maintenance treatment, follow guideline-recommended approaches 7:

  1. First-line options: Lithium or valproate for at least 2 years after the last episode 7
  2. For depressive episodes: Antidepressants (SSRIs preferred) always combined with a mood stabilizer 7
  3. Monitoring requirements: Close clinical and laboratory monitoring, preferably by a mental health specialist 7

Important Caveats

  • If considering any aripiprazole for bipolar II depression, use oral formulations at very low doses (1-5 mg) as adjunct to mood stabilizers 2
  • The long-acting injectable formulation delivers 300-400 mg monthly, which is far higher than the low doses shown effective in bipolar II depression
  • Bipolar II patients have a predominantly depressive course, and aripiprazole has not demonstrated efficacy in preventing depressive relapses 4, 5

Bottom line: Use FDA-approved mood stabilizers (lithium or valproate) for bipolar II maintenance. Abilify Maintena should be reserved for its approved indication: bipolar I disorder maintenance following a manic episode.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.